Roger Aston

Nessuna posizione attualmente

Consumer Services

Commercial Services

Health Technology

Profilo

Roger Aston served as the Chief Executive Officer at Biokine Technology Ltd.
and as the Chairman at Cambridge Drug Discovery Holdings Ltd.
He also worked as a Non-Executive Director at EyePoint Pharmaceuticals, Inc. Dr. Aston received his undergraduate and doctorate degrees from The University of Manchester.

Precedenti posizioni note di Roger Aston

Società	Posizione	Fine
Cambridge Drug Discovery Holdings Ltd. Cambridge Drug Discovery Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Charles River Laboratories International, Inc., Cambridge Drug Discovery Holdings Ltd. is a company that researches potential new drugs for the treatment of cancer. The company is based in Cambridge, UK. Cambridge Drug Discovery Holdings was acquired by Charles River Discovery Research Services UK Ltd., part of Charles River Laboratories International, Inc. from November 14, 2005 on June 11, 2001 for $38 million. The British company was founded by Barry Kenny, Jonathan Mark Treherne.	Presidente	-
Biokine Technology Ltd.	Amministratore Delegato	-
EYEPOINT PHARMACEUTICALS, INC.	Direttore/Membro del Consiglio	-

Vedi nel dettaglio l'esperienza di Roger Aston

Formazione di Roger Aston

The University of Manchester

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private